(R)-N-Boc-3-amino-4-(4-methylphenyl)butanoic acid is a chiral, non-natural amino acid derivative. Its structure features a (R)-configured stereocenter at the β-position relative to the carboxylic acid, a tert-butoxycarbonyl (Boc) protected amine group, and a 4-methylphenyl (p-tolyl) side chain. This compound serves as a key chiral building block in pharmaceutical synthesis. Its primary application is as a crucial intermediate in the synthesis of bioactive molecules, particularly in the development of protease inhibitors. For instance, it is a key chiral precursor in the synthesis of Atazanavir, a potent HIV-1 protease inhibitor used in antiretroviral therapy. The Boc-protected amine and the carboxylic acid group provide orthogonal handles for peptide coupling and further chemical elaboration, making it a versatile fragment for constructing complex drug candidates with specific stereochemistry. The compound is typically handled under standard laboratory conditions for air- and moisture-sensitive materials. Its utility lies in enabling the efficient and stereoselective construction of pharmacologically important scaffolds, contributing to the development of treatments for viral infections and other diseases.